CompletedPhase 2NCT00588523
Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma
Studying Anaplastic oligodendroglioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Thomas Kaley, MDMemorial Sloan Kettering Cancer Center
- Intervention
- temozolomide followed by high dose busulfan and thiotepa(drug)
- Enrollment
- 60 enrolled
- Eligibility
- All sexes
- Timeline
- 2002 – 2023
Study locations (3)
- Memorial Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center, Commack, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
Collaborators
University of Calgary · Northwestern University · Northwestern Memorial Hospital · Massachusetts General Hospital · Schering-Plough
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00588523 on ClinicalTrials.gov